e-therapeutics Management
Management criteria checks 3/4
e-therapeutics' CEO is Ahmad Mortazavi, appointed in Oct 2020, has a tenure of 3.75 years. total yearly compensation is £395.00K, comprised of 56.5% salary and 43.5% bonuses, including company stock and options. directly owns 8.72% of the company’s shares, worth $6.62M. The average tenure of the management team and the board of directors is 3.5 years and 4.2 years respectively.
Key information
Ahmad Mortazavi
Chief executive officer
UK£395.0k
Total compensation
| CEO salary percentage | 56.5% |
| CEO tenure | 3.8yrs |
| CEO ownership | 8.7% |
| Management average tenure | 3.5yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jan 31 2024 | UK£395k | UK£223k | -UK£11m |
| Oct 31 2023 | n/a | n/a | -UK£11m |
| Jul 31 2023 | n/a | n/a | -UK£10m |
| Apr 30 2023 | n/a | n/a | -UK£9m |
| Jan 31 2023 | UK£270k | UK£208k | -UK£8m |
| Oct 31 2022 | n/a | n/a | -UK£9m |
| Jul 31 2022 | n/a | n/a | -UK£9m |
| Apr 30 2022 | n/a | n/a | -UK£9m |
| Jan 31 2022 | UK£348k | UK£200k | -UK£8m |
| Oct 31 2021 | n/a | n/a | -UK£6m |
| Jul 31 2021 | n/a | n/a | -UK£4m |
| Apr 30 2021 | n/a | n/a | -UK£4m |
| Jan 31 2021 | UK£136k | UK£107k | -UK£4m |
Compensation vs Market: Ahmad's total compensation ($USD512.93K) is about average for companies of similar size in the US market ($USD687.60K).
Compensation vs Earnings: Ahmad's compensation has increased whilst the company is unprofitable.
CEO
Ahmad Mortazavi (53 yo)
3.8yrs
Tenure
UK£395,000
Compensation
Mr. Ahmad Ali Mortazavi serves as Chief Executive Officer at e-Therapeutics plc since October 2020 and had been its an Executive Chairman since February 10, 2020 until March 01, 2021. Mr. Mortazavi served...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.8yrs | UK£395.00k | 8.72% £ 6.6m | |
| CFO, Director of Finance & Operations and Company Secretary | 1.7yrs | no data | no data | |
| Chief Operating & Business Officer | 1.8yrs | no data | no data | |
| Chief Scientific Officer | 9.6yrs | no data | no data | |
| Head of Software Engineering | 3.5yrs | no data | no data | |
| Head of Therapeutic Discovery | 3.5yrs | no data | no data |
3.5yrs
Average Tenure
Experienced Management: ETXP.F's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 4.4yrs | UK£395.00k | 8.72% £ 6.6m | |
| Independent Non-Executive Director | 8.8yrs | UK£55.00k | 0.22% £ 168.2k | |
| Independent Non-Executive Director | 4.4yrs | UK£91.00k | 0.086% £ 65.0k | |
| Chair of Scientific Advisory Board | 4.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.8yrs | no data | no data | |
| Independent Non-Executive Chairman | less than a year | no data | no data |
4.2yrs
Average Tenure
69yo
Average Age
Experienced Board: ETXP.F's board of directors are considered experienced (4.2 years average tenure).